Ticker Scorecard - KRRO Basics Company: Korro Bio, Inc. IPO Date: October 4, 2019 Sector: Healthcare Industry: Biotech Market Cap: $246.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.91 | 4.29% Avg Daily Range (30 D): $1.23 | 3.51% Avg Daily Range (90 D): $2.31 | 4.64% Institutional Daily Volume Avg Daily Volume: .31M Avg Daily Volume (30 D): .05M Avg Daily Volume (90 D): .09M Trade Size Avg Trade Size (Sh.): 139 Avg Trade Size (Sh.) (30 D): 37 Avg Trade Size (Sh.) (90 D): 36 Institutional Trades Total Inst.Trades: 259 Avg Inst. Trade: $1.95M Avg Inst. Trade (30 D): $.73M Avg Inst. Trade (90 D): $1.65M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.79M Avg Closing Trade (30 D): $.73M Avg Closing Trade (90 D): $1.11M Avg Closing Volume: 144.04K     News Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc. May 14, 2024 @ 8:01 PM Korro Reports First Quarter 2024 Financial Results... Source: Korro Bio, Inc. Apr 18, 2024 @ 12:30 PM Korro Announces $70 Million Private Placement Source: Korro Bio, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-2.26 $-2.43 $-2.44 Diluted EPS $-2.26 $-2.43 $-2.44 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -21M $ -21.83M $ -19.56M Operating Income / Loss $ -23.29M $ -24.13M $ -21.45M Cost of Revenue $ $ $ Net Cash Flow $ -27.94M $ -49.43M $ -27.36M PE Ratio